BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37194793)

  • 1. Diagnostic potential of Type VII Collagen during oral carcinogenesis.
    Poomsawat S; Kariya A; Nimmanon T; Kosanwat T; Juengsomjit R; Sirima S
    J Appl Oral Sci; 2023; 31():e20220486. PubMed ID: 37194793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
    Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
    Watanabe M; Natsuga K; Shinkuma S; Shimizu H
    J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma.
    de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC
    Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of p-Smad3 in oral carcinogenesis.
    Poomsawat S; Punyasingh J; Vejchapipat P
    Clin Oral Investig; 2015 Apr; 19(3):613-8. PubMed ID: 25035066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
    Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
    Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study.
    Sanguansin S; Kosanwat T; Juengsomjit R; Poomsawat S
    Int J Dent; 2021; 2021():4089549. PubMed ID: 34853592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
    Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
    J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p16 in oral cancer and premalignant lesions.
    Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
    J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.
    Martins VL; Caley MP; Moore K; Szentpetery Z; Marsh ST; Murrell DF; Kim MH; Avari M; McGrath JA; Cerio R; Kivisaari A; Kähäri VM; Hodivala-Dilke K; Brennan CH; Chen M; Marshall JF; O'Toole EA
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26476432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
    Liu W; Yao Y; Shi L; Tang G; Wu L
    J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
    Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
    J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
    Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of survivin and caspase 3 in oral carcinogenesis.
    Poomsawat S; Punyasingh J; Vejchapipat P
    Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):65-71. PubMed ID: 23531848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
    Liu HW; Hu BQ; Cao CF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
    Gupta K; Metgud R; Gupta J
    J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma.
    Rahman R; Poomsawat S; Juengsomjit R; Buajeeb W
    BMC Oral Health; 2019 Jul; 19(1):142. PubMed ID: 31291930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa.
    Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT
    Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.